Impact of genomic methylation on radiation sensitivity of colorectal carcinoma.

[1]  R. Stone.  How I treat patients with myelodysplastic syndromes. , 2009, Blood.

[2]  C. Plass,et al.  The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells , 2009, Leukemia.

[3]  S. Isebaert,et al.  A systematic assessment of radiation dose enhancement by 5-Aza-2'-deoxycytidine and histone deacetylase inhibitors in head-and-neck squamous cell carcinoma. , 2009, International journal of radiation oncology, biology, physics.

[4]  Shoumei Bai,et al.  DNA methyltransferases as targets for cancer therapy. , 2007, Drugs of today.

[5]  A. Sagalowsky,et al.  The use of histone deacetylase inhibitor FK228 and DNA hypomethylation agent 5‐azacytidine in human bladder cancer therapy , 2007, International journal of cancer.

[6]  O. Kovalchuk,et al.  Epigenetic dysregulation underlies radiation-induced transgenerational genome instability in vivo. , 2006, International journal of radiation oncology, biology, physics.

[7]  G. Kristiansen,et al.  Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis , 2006, Oncogene.

[8]  I. Ciernik,et al.  Radiation therapy and combined modality treatment of gastrointestinal carcinomas. , 2006, Cancer treatment reviews.

[9]  F. Bosman,et al.  Methylation of APC, TIMP3, and TERT: a new predictive marker to distinguish Barrett's oesophagus patients at risk for malignant transformation , 2006, The Journal of pathology.

[10]  Jacqueline A. Hall,et al.  CpG island methylation of DNA damage response genes in advanced ovarian cancer. , 2005, Cancer research.

[11]  P. Ghezzi,et al.  Gene expression profiling reveals a signaling role of glutathione in redox regulation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Qian Tao,et al.  The Stress-Responsive Gene GADD45G Is a Functional Tumor Suppressor, with Its Response to Environmental Stresses Frequently Disrupted Epigenetically in Multiple Tumors , 2005, Clinical Cancer Research.

[13]  K. Camphausen,et al.  Enhancement of In vitro and In vivo Tumor Cell Radiosensitivity by the DNA Methylation Inhibitor Zebularine , 2005, Clinical Cancer Research.

[14]  W. Hohenberger,et al.  Alterations in the tissue inhibitor of metalloproteinase-3 (TIMP-3) are found frequently in human colorectal tumours displaying either microsatellite stability (MSS) or instability (MSI). , 2005, Cancer letters.

[15]  J. Benhattar,et al.  A methylation sensitive dot blot assay (MS-DBA) for the quantitative analysis of DNA methylation in clinical samples , 2005, Journal of Clinical Pathology.

[16]  M. Serrano,et al.  Inactivation of imprinted genes induced by cellular stress and tumorigenesis. , 2005, Cancer research.

[17]  J. Plumb,et al.  CpG-island methylation and epigenetic control of resistance to chemotherapy. , 2004, Biochemical Society transactions.

[18]  James B. Mitchell,et al.  Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach. , 2004, Cancer cell.

[19]  S. Belinsky,et al.  Gene-promoter hypermethylation as a biomarker in lung cancer , 2004, Nature Reviews Cancer.

[20]  I. Flinn,et al.  Azacitidine induces demethylation of the Epstein-Barr virus genome in tumors. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Yvonne Wallis,et al.  The Wnt Antagonist sFRP1 in Colorectal Tumorigenesis , 2004, Cancer Research.

[22]  J. Herman,et al.  Gene silencing in cancer in association with promoter hypermethylation. , 2003, The New England journal of medicine.

[23]  Wei Ye,et al.  Inhibition of DNA methylation and reactivation of silenced genes by zebularine. , 2003, Journal of the National Cancer Institute.

[24]  D. Riesner,et al.  Induction of Tumors in Mice by Genomic Hypomethylation , 2003 .

[25]  Matty P. Weijenberg,et al.  A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer , 2002, Nature Genetics.

[26]  K. Brown,et al.  Aberrant methylation of the ATM promoter correlates with increased radiosensitivity in a human colorectal tumor cell line , 2002, Oncogene.

[27]  Bert Vogelstein,et al.  DNMT1 and DNMT3b cooperate to silence genes in human cancer cells , 2002, Nature.

[28]  J. Herman,et al.  DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. , 2001, Human molecular genetics.

[29]  B. Iacopetta,et al.  Methylation of the hMLH1, p16, and MDR1 genes in colorectal carcinoma: associations with clinicopathological features. , 2001, Cancer letters.

[30]  J. Herman,et al.  A gene hypermethylation profile of human cancer. , 2001, Cancer research.

[31]  J. Roth,et al.  Adenovirus-mediated p16INK4a gene expression radiosensitizes non-small cell lung cancer cells in a p53-dependent manner , 2000, Oncogene.

[32]  R. Momparler,et al.  DNA methylation and cancer , 2000, Journal of cellular physiology.

[33]  K D Robertson,et al.  DNA methylation: past, present and future directions. , 2000, Carcinogenesis.

[34]  J. Herman,et al.  CpG island methylator phenotype in colorectal cancer. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Zong-hou Shen,et al.  Restoration of the p16 gene is related to increased radiosensitivity of p16-deficient lung adenocarcinoma cell lines , 1998, Journal of Cancer Research and Clinical Oncology.

[36]  Rudolf Jaenisch,et al.  DNA hypomethylation leads to elevated mutation rates , 1998, Nature.

[37]  C. Boland,et al.  Defective expression of the DNA mismatch repair protein, MLH1, alters G2-M cell cycle checkpoint arrest following ionizing radiation. , 1998, Cancer research.

[38]  P. Jones,et al.  Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines. , 1998, Cancer research.

[39]  T. Prolla,et al.  Role of DNA mismatch repair in the cytotoxicity of ionizing radiation. , 1997, Cancer research.

[40]  J. Herman,et al.  Association between CpG island methylation and microsatellite instability in colorectal cancer. , 1997, Cancer research.

[41]  L. Gerweck,et al.  Influence of experimental factors on intrinsic radiosensitivity assays at low doses of radiation: cell multiplicity. , 1994, Radiation research.

[42]  D. Haraf,et al.  Reversion of radiosensitivity in azacytidine-treated XRS5 cells does not result in full radioprotection by WR-1065. , 1992, International journal of radiation oncology, biology, physics.

[43]  N Albright,et al.  Computer programs for the analysis of cellular survival data. , 1987, Radiation research.